Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXP-LP Punctum Plug vs Xalatan in Glaucoma
NCT03318146Unknown
- Sponsor
- Shaare Zedek Medical Center
- Start
- Jun 2018
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of latanoprost in Open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Shaare Zedek Medical Center. Primary endpoint: Incidence of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v4.0 at 3 months. Status: unknown.
02
Drugs
latanoprost
03
Conditions
Open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT03318146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03318146.